Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by GILBERT COTE and ROBERT F GAGEL.
GILBERT COTE
Connection Strength
3.656
ROBERT F GAGEL
  1. Lessons learned from the management of a rare genetic cancer. N Engl J Med. 2003 Oct 16; 349(16):1566-8.
    View in: PubMed
    Score: 0.232
  2. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: Early thyroidectomy in multiple endocrine neoplasia: a four decade experience. Endocr Relat Cancer. 2020 08; 27(8):T1-T8.
    View in: PubMed
    Score: 0.186
  3. Combinations of Tyrosine Kinase Inhibitor and ERAD Inhibitor Promote Oxidative Stress-Induced Apoptosis through ATF4 and KLF9 in Medullary Thyroid Cancer. Mol Cancer Res. 2019 03; 17(3):751-760.
    View in: PubMed
    Score: 0.166
  4. Five novel mutations in the familial multiple endocrine neoplasia type 1 (MEN1) gene. Mutations in brief no. 188. Online. Hum Mutat. 1998; 12(3):219.
    View in: PubMed
    Score: 0.155
  5. Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma. Thyroid. 2016 11; 26(11):1553-1562.
    View in: PubMed
    Score: 0.143
  6. Medullary Thyroid Carcinoma Associated with Germline RETK666N Mutation. Thyroid. 2016 12; 26(12):1744-1751.
    View in: PubMed
    Score: 0.143
  7. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma. Baillieres Clin Endocrinol Metab. 1995 Jul; 9(3):609-30.
    View in: PubMed
    Score: 0.130
  8. A novel dual kinase function of the RET proto-oncogene negatively regulates activating transcription factor 4-mediated apoptosis. J Biol Chem. 2015 May 01; 290(18):11749-61.
    View in: PubMed
    Score: 0.128
  9. Identification of exon sequences and an exon binding protein involved in alternative RNA splicing of calcitonin/CGRP. Nucleic Acids Res. 1992 May 11; 20(9):2361-6.
    View in: PubMed
    Score: 0.105
  10. Validation of an in vitro RNA processing system for CT/CGRP precursor mRNA. Nucleic Acids Res. 1991 Jul 11; 19(13):3601-6.
    View in: PubMed
    Score: 0.099
  11. Calcitonin exon sequences influence alternative RNA processing. Mol Endocrinol. 1990 Nov; 4(11):1744-9.
    View in: PubMed
    Score: 0.094
  12. Transfection of calcitonin gene regulatory elements into a cell culture model of the C cell. J Bone Miner Res. 1990 Feb; 5(2):165-71.
    View in: PubMed
    Score: 0.090
  13. Calcitonin production: an examination of the regulatory effects of extracellular calcium and 1,25-dihydroxyvitamin D3. Horm Metab Res Suppl. 1989; 21:15-8.
    View in: PubMed
    Score: 0.083
  14. High resolution array-comparative genomic hybridization profiling reveals deoxyribonucleic acid copy number alterations associated with medullary thyroid carcinoma. J Clin Endocrinol Metab. 2008 Nov; 93(11):4367-72.
    View in: PubMed
    Score: 0.081
  15. The effect of 1,25-dihydroxyvitamin D3 treatment on calcitonin and calcitonin gene-related peptide mRNA levels in cultured human thyroid C-cells. Biochem Biophys Res Commun. 1987 Nov 30; 149(1):239-43.
    View in: PubMed
    Score: 0.077
  16. Studies of short-term secretion of peptides produced by alternative RNA processing. Mol Cell Endocrinol. 1987 Oct; 53(3):211-9.
    View in: PubMed
    Score: 0.076
  17. Different mechanisms of calcitonin, calcitonin gene-related peptide, and somatostatin regulation by glucocorticoids in a cell culture of human medullary thyroid carcinoma. Henry Ford Hosp Med J. 1987; 35(2-3):149-52.
    View in: PubMed
    Score: 0.072
  18. Dexamethasone differentially affects the levels of calcitonin and calcitonin gene-related peptide mRNAs expressed in a human medullary thyroid carcinoma cell line. J Biol Chem. 1986 Nov 25; 261(33):15524-8.
    View in: PubMed
    Score: 0.072
  19. The regulation of somatostatin production in human medullary thyroid carcinoma cells by dexamethasone. J Biol Chem. 1986 Oct 05; 261(28):12930-5.
    View in: PubMed
    Score: 0.071
  20. Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes? J Clin Endocrinol Metab. 2006 Aug; 91(8):2851-8.
    View in: PubMed
    Score: 0.069
  21. Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation. J Clin Endocrinol Metab. 2004 Aug; 89(8):4142-5.
    View in: PubMed
    Score: 0.061
  22. Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene. J Clin Invest. 2002 Dec; 110(12):1849-57.
    View in: PubMed
    Score: 0.055
  23. Naturally occurring heterologous trans-splicing of adenovirus RNA with host cellular transcripts during infection. FEBS Lett. 2002 Jul 03; 522(1-3):41-6.
    View in: PubMed
    Score: 0.053
  24. Promiscuity of pre-mRNA spliceosome-mediated trans splicing: a problem for gene therapy? Hum Gene Ther. 2001 Jul 20; 12(11):1429-41.
    View in: PubMed
    Score: 0.050
  25. Structure of the mouse calcitonin/calcitonin gene-related peptide alpha and beta genes. DNA Seq. 2001; 12(2):131-5.
    View in: PubMed
    Score: 0.048
  26. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The state of science in medullary thyroid carcinoma: current challenges and unmet needs. Endocr Relat Cancer. 2020 08; 27(8):T27-T39.
    View in: PubMed
    Score: 0.046
  27. Multiple endocrine neoplasias. Annu Rev Physiol. 2000; 62:377-411.
    View in: PubMed
    Score: 0.045
  28. Calcium-induced activation of a mutant G-protein-coupled receptor causes in vitro transformation of NIH/3T3 cells. Neoplasia. 1999 Dec; 1(6):485-91.
    View in: PubMed
    Score: 0.044
  29. Hammerhead ribozyme-mediated inactivation of mutant RET in medullary thyroid carcinoma. Cancer Res. 1999 Aug 15; 59(16):3911-4.
    View in: PubMed
    Score: 0.043
  30. A codon 891 exon 15 RET proto-oncogene mutation in familial medullary thyroid carcinoma: a detection strategy. Mol Cell Probes. 1999 Feb; 13(1):77-9.
    View in: PubMed
    Score: 0.042
  31. The surgical treatment of medullary thyroid carcinoma. Semin Surg Oncol. 1999 Jan-Feb; 16(1):50-63.
    View in: PubMed
    Score: 0.042
  32. Mutational analysis of the GDNF/RET-GDNFR alpha signaling complex in a kindred with vesicoureteral reflux. Hum Genet. 1998 Apr; 102(4):474-8.
    View in: PubMed
    Score: 0.039
  33. Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma. Ann Surg Oncol. 2018 May; 25(5):1395-1402.
    View in: PubMed
    Score: 0.039
  34. Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness. J Clin Endocrinol Metab. 2017 08 01; 102(8):2807-2813.
    View in: PubMed
    Score: 0.038
  35. All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patients. Fam Cancer. 2017 04; 16(2):283-289.
    View in: PubMed
    Score: 0.037
  36. Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab. 1996 Oct; 81(10):3740-5.
    View in: PubMed
    Score: 0.036
  37. RET protooncogene mutational analysis in multiple endocrine neoplasia syndrome type 2B: case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 Sep; 82(3):288-94.
    View in: PubMed
    Score: 0.035
  38. Inactivation of the first nucleotide-binding fold of the sulfonylurea receptor, and familial persistent hyperinsulinemic hypoglycemia of infancy. Am J Hum Genet. 1996 Sep; 59(3):510-8.
    View in: PubMed
    Score: 0.035
  39. Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2. Endocrinol Metab Clin North Am. 1996 Mar; 25(1):1-25.
    View in: PubMed
    Score: 0.034
  40. The molecular basis for familial persistent hyperinsulinemic hypoglycemia of infancy. Proc Assoc Am Physicians. 1996 Jan; 108(1):14-9.
    View in: PubMed
    Score: 0.034
  41. An intron enhancer containing a 5' splice site sequence in the human calcitonin/calcitonin gene-related peptide gene. Mol Cell Biol. 1995 Dec; 15(12):7135-42.
    View in: PubMed
    Score: 0.034
  42. Clinical use of molecular information in the management of multiple endocrine neoplasia type 2A. J Intern Med. 1995 Oct; 238(4):333-41.
    View in: PubMed
    Score: 0.033
  43. Identification of a polymorphism in exon 11 of the RET protooncogene. Hum Mol Genet. 1994 Dec; 3(12):2263.
    View in: PubMed
    Score: 0.031
  44. The calcitonin exon and its flanking intronic sequences are sufficient for the regulation of human calcitonin/calcitonin gene-related peptide alternative RNA splicing. Mol Endocrinol. 1994 Dec; 8(12):1618-26.
    View in: PubMed
    Score: 0.031
  45. Direct sequencing of PCR products in agarose gel slices. Nucleic Acids Res. 1994 Aug 25; 22(16):3425-6.
    View in: PubMed
    Score: 0.031
  46. Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations. Thyroid. 2014 Jul; 24(7):1096-106.
    View in: PubMed
    Score: 0.030
  47. The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2. J Clin Endocrinol Metab. 2013 Nov; 98(11):E1813-9.
    View in: PubMed
    Score: 0.029
  48. Deletion of the gene encoding calcitonin and calcitonin gene-related peptide a does not affect the outcome of severe infection in mice. Am J Respir Cell Mol Biol. 2013 Jul; 49(1):151-5.
    View in: PubMed
    Score: 0.028
  49. Transcription of the human calcitonin gene is mediated by a C cell-specific enhancer containing E-box-like elements. Mol Endocrinol. 1990 Nov; 4(11):1750-7.
    View in: PubMed
    Score: 0.024
  50. 1,25-Dihydroxyvitamin D3 silences 3',5'-cyclic adenosine monophosphate enhancement of somatostatin gene transcription in human thyroid C cells. Mol Endocrinol. 1989 Mar; 3(3):547-51.
    View in: PubMed
    Score: 0.021
  51. Transcriptional regulation of the human calcitonin gene: a progress report. Henry Ford Hosp Med J. 1989; 37(3-4):194-7.
    View in: PubMed
    Score: 0.021
  52. Expression analysis of fibroblast growth factor-23, matrix extracellular phosphoglycoprotein, secreted frizzled-related protein-4, and fibroblast growth factor-7: identification of fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein as major factors involved in tumor-induced osteomalacia. Endocr Pract. 2008 Dec; 14(9):1108-14.
    View in: PubMed
    Score: 0.021
  53. Recent advances in thyroid cancer. In brief. Curr Probl Surg. 2008 Mar; 45(3):149-51.
    View in: PubMed
    Score: 0.020
  54. Recent advances in thyroid cancer. Curr Probl Surg. 2008 Mar; 45(3):156-250.
    View in: PubMed
    Score: 0.020
  55. Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. World J Surg. 2006 May; 30(5):643-53.
    View in: PubMed
    Score: 0.017
  56. RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors. Thyroid. 2005 Jun; 15(6):531-44.
    View in: PubMed
    Score: 0.016
  57. A novel point mutation of the RET protooncogene involving the second intracellular tyrosine kinase domain in a family with medullary thyroid carcinoma. J Clin Endocrinol Metab. 2004 Jul; 89(7):3521-6.
    View in: PubMed
    Score: 0.015
  58. The role of genetics in the surgical management of familial endocrinopathy syndromes. J Am Coll Surg. 2003 Nov; 197(5):818-31.
    View in: PubMed
    Score: 0.015
  59. Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship. Arch Surg. 2003 Apr; 138(4):409-16; discussion 416.
    View in: PubMed
    Score: 0.014
  60. Genotype-phenotype analysis in multiple endocrine neoplasia type 1. Arch Surg. 2002 Jun; 137(6):641-7.
    View in: PubMed
    Score: 0.013
  61. [Germline mutations of the ret proto-oncogene in Chilean patients with hereditary and sporadic medullary thyroid carcinoma]. Rev Med Chil. 2001 Jul; 129(7):713-8.
    View in: PubMed
    Score: 0.012
  62. Arthritic calcitonin/alpha calcitonin gene-related peptide knockout mice have reduced nociceptive hypersensitivity. Pain. 2001 Jan; 89(2-3):265-73.
    View in: PubMed
    Score: 0.012
  63. Screening for MEN1 mutations in patients with atypical endocrine neoplasia. Surgery. 1999 Dec; 126(6):1097-103; discussion 1103-4.
    View in: PubMed
    Score: 0.011
  64. Surgical strategy for the treatment of medullary thyroid carcinoma. Ann Surg. 1999 Nov; 230(5):697-707.
    View in: PubMed
    Score: 0.011
  65. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA. 1996 Nov 20; 276(19):1575-9.
    View in: PubMed
    Score: 0.009
  66. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science. 1995 Apr 21; 268(5209):426-9.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.